BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 17325225)

  • 1. Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase.
    Kahn JN; Garcia-Effron G; Hsu MJ; Park S; Marr KA; Perlin DS
    Antimicrob Agents Chemother; 2007 May; 51(5):1876-8. PubMed ID: 17325225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
    Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically significant micafungin resistance in Candida albicans involves modification of a glucan synthase catalytic subunit GSC1 (FKS1) allele followed by loss of heterozygosity.
    Niimi K; Monk BC; Hirai A; Hatakenaka K; Umeyama T; Lamping E; Maki K; Tanabe K; Kamimura T; Ikeda F; Uehara Y; Kano R; Hasegawa A; Cannon RD; Niimi M
    J Antimicrob Chemother; 2010 May; 65(5):842-52. PubMed ID: 20233776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum differentially alters the antifungal properties of echinocandin drugs.
    Paderu P; Garcia-Effron G; Balashov S; Delmas G; Park S; Perlin DS
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2253-6. PubMed ID: 17420211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired echinocandin resistance in a Candida krusei blood isolate confirmed by mutations in the fks1 gene.
    Prigitano A; Esposito MC; Cogliati M; Pitzurra L; Santamaria C; Tortorano AM
    New Microbiol; 2014 Apr; 37(2):237-40. PubMed ID: 24858652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echinocandin resistance in Candida species: mechanisms of reduced susceptibility and therapeutic approaches.
    Beyda ND; Lewis RE; Garey KW
    Ann Pharmacother; 2012; 46(7-8):1086-96. PubMed ID: 22811350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of L701 M mutation in the FKS1 gene of echinocandin-susceptible Candida krusei isolates.
    Lallitto F; Prigitano A; Mangione F; Piralla A; Tamarozzi F; Marone P; Cavanna C
    Diagn Microbiol Infect Dis; 2018 Dec; 92(4):311-314. PubMed ID: 30131237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the fks1 gene in Candida albicans, C. tropicalis, and C. krusei correlate with elevated caspofungin MICs uncovered in AM3 medium using the method of the European Committee on Antibiotic Susceptibility Testing.
    Desnos-Ollivier M; Bretagne S; Raoux D; Hoinard D; Dromer F; Dannaoui E;
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3092-8. PubMed ID: 18591282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reconstitution of high-level micafungin resistance detected in a clinical isolate of Candida glabrata identifies functional homozygosity in glucan synthase gene expression.
    Niimi K; Woods MA; Maki K; Nakayama H; Hatakenaka K; Chibana H; Ikeda F; Ueno K; Niimi M; Cannon RD; Monk BC
    J Antimicrob Chemother; 2012 Jul; 67(7):1666-76. PubMed ID: 22514266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis.
    Laverdière M; Lalonde RG; Baril JG; Sheppard DC; Park S; Perlin DS
    J Antimicrob Chemother; 2006 Apr; 57(4):705-8. PubMed ID: 16464893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired resistance to echinocandins in Candida albicans: case report and review.
    Baixench MT; Aoun N; Desnos-Ollivier M; Garcia-Hermoso D; Bretagne S; Ramires S; Piketty C; Dannaoui E
    J Antimicrob Chemother; 2007 Jun; 59(6):1076-83. PubMed ID: 17468115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candida albicans and Candida dubliniensis respond differently to echinocandin antifungal agents in vitro.
    Jacobsen MD; Whyte JA; Odds FC
    Antimicrob Agents Chemother; 2007 May; 51(5):1882-4. PubMed ID: 17307974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis.
    Melkusová S; Bujdáková H; Volleková A; Myoken Y; Mikami Y
    Pharmazie; 2004 Jul; 59(7):573-4. PubMed ID: 15296100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target enzyme mutations confer differential echinocandin susceptibilities in Candida kefyr.
    Staab JF; Neofytos D; Rhee P; Jiménez-Ortigosa C; Zhang SX; Perlin DS; Marr KA
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5421-7. PubMed ID: 24982083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micafungin: a new echinocandin.
    Chandrasekar PH; Sobel JD
    Clin Infect Dis; 2006 Apr; 42(8):1171-8. PubMed ID: 16575738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy.
    Hakki M; Staab JF; Marr KA
    Antimicrob Agents Chemother; 2006 Jul; 50(7):2522-4. PubMed ID: 16801435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A naturally occurring proline-to-alanine amino acid change in Fks1p in Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis accounts for reduced echinocandin susceptibility.
    Garcia-Effron G; Katiyar SK; Park S; Edlind TD; Perlin DS
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2305-12. PubMed ID: 18443110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus.
    Satish S; Jiménez-Ortigosa C; Zhao Y; Lee MH; Dolgov E; Krüger T; Park S; Denning DW; Kniemeyer O; Brakhage AA; Perlin DS
    mBio; 2019 Jun; 10(3):. PubMed ID: 31164462
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro activity of echinocandins against non-Candida albicans: is echinocandin antifungal activity the same?
    Espinel-Ingroff A; Cantón E
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():3-9. PubMed ID: 21420570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.